Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Hirotaka Iwase Author

kou_susan@yahoo.co.jp

Subjects of specialization
Mucoepidermoid carcinoma, Cancer chemotherapy, Prostate biomarker

Affiliation
Kumamoto University Hospital Cancer Center, Kumamoto, Japan. Department of Breast and Endocrine Surgery, Kumamoto University, Kumamoto, Japan

Biography

Hirotaka Iwase was working in the Department of Breast and Endocrine Surgery, Kumamoto University, Kumamoto, Japan. He has more than 40 publications. His current research area related to osteoarthropathy.

Publications

Review Article Subscription

Chemotherapy for Patients with Renal Dysfunction

Author(s):

Koichi Suyama, Yuji Miura, Toshimi Takano and Hirotaka Iwase

Significant progress has been made in systemic chemotherapies for advanced cancer patients. Historically, the main anticancer drugs were cytotoxic agents, but recently, other agents such as molecularly-targeted therapies and immune checkpoint inhibitors have been introduced into clinical practice, and these agents have begun to achieve mainstream usage. The rapid development of novel anticancer drugs has forced clinicians to consider the effects of these chemotherapy agents in high-risk patients with liver or renal dysfunction, those undergoing dialysis and the elderly. Currently, there are no clear guidelines describing the best practices for anticancer drug administration in patients with renal dysfunction. However, the theory that renal dysfunction affect... view more»

DOI: 10.4172/2324-9110.1000174

Abstract HTML PDF

Google Scholars / Researchers Sites

Explore SciTechnol

GET THE APP